Flawed attention-deficit/hyperactivity disorder medication comparison [6] (multiple letters)

Pediatrics

Volumn 114, Issue 4, 2004, Pages 1132-1133

  Adesman, Andrew ^a   Swanson, James M ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LETTER; METHODOLOGY; PATIENT; PEDIATRICIAN; PRIORITY JOURNAL; CHILD; DELAYED RELEASE FORMULATION; NOTE; PHARMACOKINETICS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DELAYED-ACTION PREPARATIONS; HUMANS; METHYLPHENIDATE; RESEARCH DESIGN; THERAPEUTIC EQUIVALENCY;

EID: 16644400690     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1310     Document Type: Letter

References (0)